Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 419-425

  Al Khadra, Ayman S ^a   Salem, Deeb N ^a   Rand, William M ^a   Udelson, James E ^a   Smith, John J ^a   Konstam, Marvin A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; NITRATE; PLACEBO; POTASSIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIAC OUTPUT, LOW; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT ADMISSION; PLACEBOS; PLATELET AGGREGATION INHIBITORS; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0031955764     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00502-0     Document Type: Article

References (31)

1. Effect of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N Engl J Med. 316:1987;1429-1435.
2. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction. Lancet. 2:1988;349-360.
3. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 321:1989;129-135.
4. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 319:1988;1105-1111.
5. Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation. 80:1989;749-756.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
7. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;310-318.
8. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 243:1980;661-669.
9. Klimt CR, Kratterud GL, Stamler J, Meier P. The Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol. 7:1986;251-269.
10. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med. 90:1991;42S-47S.
11. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 121:1994;289-300.
12. Oates JA. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs. Hypertension. 11:1988;II-4-II-6.
13. Riegger GA, Kahles HW, Elsner D, Kromer EP, Kochsiek K. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure. Am J Med. 90:1991;571-575.
14. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
15. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
16. Studies of Left Ventricular Dysfunction (SOLVD) - rationale, design, and methods two trials that evaluate the effect of enalapril in patients with reduced ejection fraction . Am J Cardiol. 66:1990;315-322.
17. Stein B, Fuster V. Clinical pharmacology of platelet inhibitors. Fuster V, Verstraete M. Thrombosis in Cardiovascular Disorders. vol. 5:1992;99-119 WB Saunders.
18. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure relation to the activation of the renin-angiotensin system and hyponatremia . N Engl J Med. 310:1984;347-352.
19. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension. 18:1991;158-164.
20. Baur LHB, Schipperheyn JJ, Van der Laarse A, et al. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J. 73:1995;227-236.
21. Jeserich M, Pape L, Just H, et al. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol. 76:1995;1079-1082.
22. Kalkman EAJ, van Suylen RJ, van Dijk JPM, Saxena PR, Schoemaker RG. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat. J Mol Cell Cardiol. 27:1995;2483-2494.
23. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibit the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res. 78:1996;759-768.
24. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
25. O'Murchu B, Miller VM, Perrella MA, Burnett JC Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 93:1994;165-171.
26. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
27. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effect of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 20:1992;1549-1555.
28. van Wijngaarden J, Smit AJ, de Graeff PA, et al. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 23:1994;240-245.
29. Evans MA, Burnett JC Jr, Redfield MM. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure. J Am Coll Cardiol. 25:1995;1445-1450.
30. McGiff R, Terragno N, Malik KU, Longro AJ. Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res. 31:1972;36-43.
31. Swartz SL, Williams GH, Hollenberg NK, et al. Increase in prostaglandins during converting enzyme inhibition. Clin Sci. 59:(Suppl 6):1980;133S-135S.